Titre (en)
Analysis
France
Racine
Analysis
France
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Analysis (France)

Index « Titre (en) » - entrée « clinical »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
clearance < clinical < clinicians  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 52.
[20-40] [0 - 20][0 - 50][40-51][40-60]
Ident.Authors (with country if any)Title
000369 (2015) A-P Trouvin ; S. Jacquot [France] ; S. Grigioni [France] ; E. Curis [France] ; I. Dedreux [France] ; A. Roucheux [France] ; H. Boulard ; O. Vittecoq [France] ; X. Le Loët ; O. Boyer [France] ; V. Goëb [France]Usefulness of monitoring of B cell depletion in rituximab-treated rheumatoid arthritis patients in order to predict clinical relapse: a prospective observational study
000375 (2015) Clémentine Fortunet [France] ; Yves-Marie Pers [France] ; Joseph Lambert [France] ; Marie Godfrin-Valnet [France] ; Elodie Constant [France] ; Hervé Devilliers [France] ; Philippe Gaudin [France] ; Christian Jorgensen [France] ; Béatrice Pallot Prades [France] ; Daniel Wendling [France] ; Jean Francis Maillefert [France]Tocilizumab induces corticosteroid sparing in rheumatoid arthritis patients in clinical practice.
000380 (2015) Ozan Ünlü [États-Unis] ; Stephane Zuily [France] ; Doruk Erkan [États-Unis]The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus
000401 (2015) Vivian P. Bykerk [États-Unis] ; Andrew J. K. Östör [Royaume-Uni] ; José Alvaro-Gracia [Espagne] ; Karel Pavelka [République tchèque] ; José Andrés Román Ivorra [Espagne] ; Winfried Graninger [Autriche] ; William Bensen ; Michael T. Nurmohamed [Pays-Bas] ; Andreas Krause [Allemagne] ; Corrado Bernasconi [Suisse] ; Maher Aassi [Suisse] ; Jean Sibilia [France]Erratum to: Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice
000410 (2015) Vivian P. Bykerk [États-Unis] ; Andrew J. K. Östör [Royaume-Uni] ; José Alvaro-Gracia [Espagne] ; Karel Pavelka [République tchèque] ; José Andrés Román Ivorra [Espagne] ; Winfried Graninger [Autriche] ; William Bensen ; Michael T. Nurmohamed [Pays-Bas] ; Andreas Krause [Allemagne] ; Corrado Bernasconi [Suisse] ; Maher Aassi [Suisse] ; Jean Sibilia [France]Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice
000411 (2015) Clémentine Fortunet [France] ; Jean Francis Maillefert [France]Comment on: tocilizumab induces corticosteroid sparing in rheumatoid arthritis patients in clinical practice: reply.
000412 (2015) David Ternant [France] ; Theodora Bejan-Angoulvant [France] ; Christophe Passot [France] ; Denis Mulleman [France] ; Gilles Paintaud [France]Clinical Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies Approved to Treat Rheumatoid Arthritis.
000413 (2015) A. Woerner [France, Suisse] ; F. Uettwiller [France] ; I. Melki [France] ; R. Mouy [France] ; C. Wouters [France, Belgique] ; B. Bader-Meunier [France] ; P. Quartier [France]Biological treatment in systemic juvenile idiopathic arthritis: achievement of inactive disease or clinical remission on a first, second or third biological agent
000415 (2015) Josef S. Smolen ; Jürgen Wollenhaupt [Allemagne] ; Juan J. Gomez-Reino [Espagne] ; Walter Grassi [Italie] ; Corine Gaillez [France] ; Coralie Poncet [France] ; Manuela Le Bars [France] ; Rene Westhovens [Belgique]Attainment and characteristics of clinical remission according to the new ACR-EULAR criteria in abatacept-treated patients with early rheumatoid arthritis: new analyses from the Abatacept study to Gauge Remission and joint damage progression in methotrexate (MTX)-naive patients with Early Erosive rheumatoid arthritis (AGREE)
000429 (2014) P. Kieffer [France] ; O. Hinschberger [France] ; E. Ciobanu [France] ; F. Jaeger-Bizet [France] ; A. Drabo [France] ; T. Mostoufizadeh [France] ; L. Martzolff [France][Clinical and biological efficacy of tocilizumab in giant cell arteritis: report of three patients and literature review].
000444 (2014) Yves-Marie Pers [France] ; Clémentine Fortunet ; Elodie Constant ; Joseph Lambert ; Marie Godfrin-Valnet ; Audrey De Jong ; Grégoire Mercier ; Béatrice Pallot Prades ; Daniel Wendling ; Philippe Gaudin ; Christian Jorgensen ; Hubert Marotte ; Jean-Francis MaillefertPredictors of response and remission in a large cohort of rheumatoid arthritis patients treated with tocilizumab in clinical practice.
000458 (2014) Maya H. Buch [Royaume-Uni] ; Lucia Silva-Fernandez [Espagne] ; Loreto Carmona [Espagne] ; Daniel Aletaha [Autriche] ; Robin Christensen [Danemark] ; Bernard Combe [France] ; Paul Emery [Royaume-Uni] ; Gianfranco Ferraccioli [Italie] ; Francis Guillemin [France] ; Tore K. Kvien [Norvège] ; Robert Landewe [Pays-Bas] ; Karel Pavelka [République tchèque] ; Kenneth Saag [États-Unis] ; Josef S. Smolen [Autriche] ; Deborah Symmons [Royaume-Uni] ; Désirée Van Der Heijde [Pays-Bas] ; Joep Welling [Pays-Bas] ; George Wells [Canada] ; Rene Westhovens [Belgique] ; Angela Zink [Allemagne] ; Maarten Boers [Pays-Bas]Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology
000460 (2014) Eli L. Diamond [États-Unis] ; Lorenzo Dagna [Italie] ; David M. Hyman [États-Unis] ; Giulio Cavalli [Italie] ; Filip Janku [États-Unis] ; Juvianee Estrada-Veras [États-Unis] ; Marina Ferrarini [Italie] ; Omar Abdel-Wahab [États-Unis] ; Mark L. Heaney [États-Unis] ; Paul J. Scheel [États-Unis] ; Nancy K. Feeley [États-Unis] ; Elisabetta Ferrero [Italie] ; Kenneth L. Mcclain [États-Unis] ; Augusto Vaglio [Italie] ; Thomas Colby [États-Unis] ; Laurent Arnaud [France] ; Julien Haroche [France]Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease
000461 (2014) Maxime Dougados [France] ; Karsten Kissel [Australie] ; Philip G. Conaghan [Royaume-Uni] ; Emilio Martin Mola [Espagne] ; Georg Schett [Allemagne] ; Roberto Gerli [Italie] ; Michael Sejer Hansen [Danemark] ; Howard Amital [Israël] ; Ricardo M. Xavier [Brésil] ; Orrin Troum [États-Unis] ; Corrado Bernasconi [Suisse] ; T W J. Huizinga [Pays-Bas]Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: the ACT-RAY study
000462 (2014) T W J. Huizinga [Pays-Bas] ; Philip G. Conaghan [Royaume-Uni] ; Emilio Martin-Mola [Espagne] ; Georg Schett [Allemagne] ; Howard Amital [Israël] ; Ricardo M. Xavier [Brésil] ; Orrin Troum [États-Unis] ; Maher Aassi ; Corrado Bernasconi ; Maxime Dougados [France]Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study
000484 (2013) V P Bykerk [États-Unis] ; J. Cush [États-Unis] ; K. Winthrop [États-Unis] ; L. Calabrese [États-Unis] ; O. Lortholary [France] ; M. De Longueville [Belgique] ; R. Van Vollenhoven [Suède] ; X. Mariette [France]Update on the safety profile of certolizumab pegol in rheumatoid arthritis: an integrated analysis from clinical trials
000495 (2013) Audrey Pierreisnard [France] ; Nahema Issa ; Thomas Barnetche ; Christophe Richez ; Thierry SchaeverbekeMeta-analysis of clinical and radiological efficacy of biologics in rheumatoid arthritis patients naive or inadequately responsive to methotrexate.
000534 (2013) Y.-M. Pers [France] ; C. Fortunet ; E. Constant ; J. Lambert [France] ; A. Mazouyes [France] ; M. Valnet [France] ; H. Marotte ; P. Gaudin [France] ; D. Wendling [France] ; J.-F. Maillefert ; C. Jorgensen [France]THU0126 Multicenter retrospective study: Response to tocilizumab in clinical practice is not influenced by the number of previous biotherapy or by association with a DMARD
000537 (2013) M. Dougados [France] ; K. Kissel [Suisse] ; P. G. Conaghan [Royaume-Uni] ; E. Martin-Mola [Espagne] ; G. Schett [Allemagne] ; H. Amital [Israël] ; R. M. Xavier [Brésil] ; O. Troum [États-Unis] ; C. Bernasconi [Suisse] ; T. W. J. Huizinga [Pays-Bas]THU0093 Clinical, radiographic, and immunogenic effects after 1 year of tocilizumab (TCZ)-based treatment strategy with and without methotrexate (MTX) in RA: The act-ray study
000545 (2013) J. Mélet ; D. Mulleman ; P. Goupille ; B. Ribourtout [France] ; H. Watier [France] ; G. Thibault [France]SAT0102 Rituximab-Induced T-Cell Depletion in Patients with Rheumatoid Arthritis: Association With Clinical Response
000554 (2013) T. W. J. Huizinga [Pays-Bas] ; T. Donka [Suisse] ; P. G. Conaghan [Royaume-Uni] ; E. Martin-Mola [Espagne] ; G. Schett [Allemagne] ; H. Amital [Israël] ; R. M. Xavier [Brésil] ; O. Troum [États-Unis] ; C. Bernasconi [Suisse] ; M. Dougados [France]OP0042 Clinical and Radiographic Outcomes at Two Years and the Effect of Tocilizumab (TCZ) Discontinuation Following Sustained Remission in the Second Year of the Act-Ray Study

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/France/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Title.i -k "clinical" 

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Title.i  \
                -Sk "clinical" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Title.i
   |clé=    clinical
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021